El nivel del razonamiento lógico matemático de los estudiantes del Instituto Superior Tecnológico Público Cutervo de la Región Cajamarca

El objetivo de este trabajo de investigación fue hacer un diagnóstico del nivel del razonamiento lógico matemático de los estudiantes que ingresaban al Instituto Superior Tecnológico Público Cutervo, puesto que deseábamos conocer el estado del desarrollo de esta capacidad tan importante en la vida de toda persona y en especial de futuros profesionales. Sabemos que, en la actualidad, en la mayoría de los países desarrollados, para el ingreso a las universidades ya no se evalúan conocimientos sino el nivel de las capacidades, en resumen, el nivel del razonamiento lógico matemático y el razonamiento verbal. En nuestro caso, se utilizó una prueba objetiva de selección múltiple que se aplicó a los estudiantes que habían recién ingresado a la institución. Los resultados han demostrado que el nivel del razonamiento lógico matemático de la muestra es regular, con un promedio de 14,76.The objective of this research work was to make a diagnosis of the level of mathematical logical reasoning of the students who entered the Cutervo Public Higher Technological Institute, since we wanted to know the state of the development of this capacity that is so important in the life of every person and in special for future professionals. We know that, currently, in most developed countries, knowledge is no longer evaluated for admission to universities, but rather the level of skills, in short, the level of mathematical logical reasoning and verbal reasoning. In our case, an objective multiple-choice test was applied to students who had just entered the institution. The results have shown that the level of mathematical logical reasoning of the sample is regular, with an average of 14.76

RICORS2040 : The need for collaborative research in chronic kidney disease

Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is 'solved' by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020-2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true

Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

Cardiopoietic cells, produced through cardiogenic conditioning of patients' mesenchymal stem cells, have shown preliminary efficacy. The Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) trial aimed to validate cardiopoiesis-based biotherapy in a larger heart failure cohort

Sedacion controlada en pacientes ventilados mecanicamente Analisis comparativo de metodos de administracion y efectos clinicos

Centro de Informacion y Documentacion Cientifica (CINDOC). C/Joaquin Costa, 22. 28002 Madrid. SPAIN / CINDOC - Centro de Informaciòn y Documentaciòn CientìficaSIGLEESSpai

State of the Art: Newer biomarkers in heart failure

Since natriuretic peptides were successfully integrated into the clinical practice of heart failure (HF), the possibility of using new biomarkers to advance the management of affected patients has been explored. While a huge number of candidate HF biomarkers have been described recently, very few have made the difficult translation from initial promise to clinical application. These markers mirror the complex pathophysiology of heart failure at various levels: cell loss (troponin), fibrosis (ST2 and galectin-3), infection (procalcitonin), and renal disease (several renal markers). In this review, we examine the best emerging candidates for clinical assessment and management of patients with HF